pillbase.ru

Suliqua

Active substance: insulin glargine, lixisenatide

insulin glargine, lixisenatide

Centralised EU authorisationActive

Marketing holder: Sanofi Winthrop Industrie

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Products containing insulin glargine in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
US 23
  • BASAGLAR KwikPen
    INJECTION, SOLUTION · INSULIN GLARGINE 100 [iU]/mL
    0002-7715
    Eli Lilly and Company
  • INSULIN GLARGINE
    INJECTION, SOLUTION · INSULIN GLARGINE 100 [iU]/mL
    72572-424
    Civica, Inc.
  • INSULIN GLARGINE
    INJECTION, SOLUTION · INSULIN GLARGINE 100 [iU]/mL
    72572-422
    Civica, Inc.
  • Insulin 1556
    LIQUID · INSULIN GLARGINE 9 [hp_X]/29.5mL
    63083-1556
    Professional Complementary Health Formulas
  • Insulin Glargine
    INJECTION, SOLUTION · INSULIN GLARGINE 100 [iU]/mL
    83257-015
    Biocon Biologics Inc.
All products in this country (23)
Registration
Registration number
EMEA/H/C/004243
Registration status
Active
ATC code
A10AE54
Sources
  • product · EMA · EMEA/H/C/004243 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004243 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004243 · Verified 2026-10-09
  • ingredients.1 · EMA · EMEA/H/C/004243 · Verified 2026-10-09